Skip to main content
    G

    Grifols SA ADR (GRFS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $8.73
    +0.04 (+0.46%)

    Market Cap: $5.91B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Grifols SA ADR (GRFS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Grifols SA ADR are Organon (OGN), GSK (GSK) and Biogen (BIIB). Grifols SA ADR trades at 9.9x earnings, against a median of 21.4x for the 7 of these companies with a P/E. By market cap, Grifols SA ADR ranks 9th of the 12 companies on this page; Gilead Sciences (GILD) is the largest at $208.48B.

    Peer Comparison

    GRFS's ROIC of 7.6% is above the peer median of 5.2%, and its revenue growth of 9.4% is above the median of 6.8%. It yields 1.08%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Grifols SA ADR (GRFS)$5.91B9.9x0.7x6.4%7.6%9.4%1.08%
    Organon & Co (OGN)$3.65B4.6x0.6x3.5%6.2%-1.7%0.58%
    GSK plc (GSK)$101.13B10.5x2.3x13.0%N/A4.0%3.58%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    GRAIL, LLC (GRAL)$5.21BN/A29.6x-243.8%N/A3.7%0.00%
    Sanofi ADR (SNY)$116.15BN/A2.0x8.2%7.6%15.7%5.01%
    Bristol-Myers Squibb Company (BMY)$129.66B10.1x2.6x18.5%13.9%6.9%4.00%
    Gilead Sciences Inc (GILD)$208.48BN/A6.7x-12.5%-3.9%6.8%1.96%
    Bio-Rad Laboratories Inc (BIO)$9.85B37.3x3.7x39.5%4.1%0.5%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Kodiak Sciences Inc (KOD)$7.27BN/AN/A0.0%-1481.8%0.0%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    Peer median$9.85B21.4x3.7x8.2%5.2%6.8%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 11 companies most similar to Grifols SA ADR, ranked by how closely their business, size, sector and industry match. The largest group, 6 of the 11, is in Drug Manufacturers - General; the other 5 span 3 industries.

    CompanyAboutPeers
    Organon & Co (OGN)Drug Manufacturers - General
    Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey.
    OGN competitors
    GSK plc (GSK)Drug Manufacturers - General
    GlaxoSmithKline plc is dedicated to the creation, discovery, development, manufacture and marketing of pharmaceuticals, vaccines...
    GSK competitors
    Biogen Inc (BIIB)Drug Manufacturers - General
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    GRAIL, LLC (GRAL)Diagnostics & Research
    GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics...
    GRAL competitors
    Sanofi ADR (SNY)Drug Manufacturers - General
    Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe...
    SNY competitors
    Bristol-Myers Squibb Company (BMY)Drug Manufacturers - General
    Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City.
    BMY competitors
    Gilead Sciences Inc (GILD)Drug Manufacturers - General
    Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California...
    GILD competitors
    Bio-Rad Laboratories Inc (BIO)Medical Devices
    Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical...
    BIO competitors
    TG Therapeutics Inc (TGTX)Biotechnology
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Kodiak Sciences Inc (KOD)Biotechnology
    Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing...
    KOD competitors
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors

    Frequently Asked Questions About GRFS

    Who are Grifols SA ADR's main competitors?

    The companies most similar to Grifols SA ADR include Organon (OGN), GSK (GSK), Biogen (BIIB), GRAIL, LLC (GRAL) and Sanofi ADR (SNY), listed from the closest match.

    Who is Grifols SA ADR's biggest competitor?

    Gilead Sciences (GILD) is the largest of the similar companies at $208.48B; Organon (OGN) is the closest match by business profile, size, sector and industry.

    How does GRFS stock compare with its competitors?

    GRFS' P/E is 9.9x against a peer median of 21.4x; its P/S is 0.7x against a peer median of 3.7x; its net margin is 6.4% against a peer median of 8.2%.

    Which of Grifols SA ADR's competitors pays a higher dividend?

    Grifols SA ADR has a forward dividend yield of 1.08%. Sanofi ADR (SNY), Bristol-Myers Squibb Company (BMY), GSK (GSK) and Gilead Sciences (GILD) have higher forward dividend yields; Sanofi ADR (SNY) has the highest at 5.01%.

    Is Grifols SA ADR bigger than its competitors?

    No. Grifols SA ADR is 9th by market cap among the 12 companies on this page; the largest is Gilead Sciences (GILD) at $208.48B.